Molecular characterization and clinical treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients with TP53 mutation
Mutations in TP53 in myeloid neoplasms patients have been associated with poor prognosis. Effective treatments to these patients remain unclear.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Yanfen Li, Hua Wan, Yu Jing Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Lymphoma | Myelodysplastic Syndrome | Myeloma